| 2.03 -0.17 (-7.73%) | 06-24 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 3 | 1-year : | 3.5 |
| Resists | First : | 2.56 | Second : | 3 |
| Pivot price | 2  |
|||
| Supports | First : | 1.77  |
Second : | 1.27 |
| MAs | MA(5) : | 2.03 |
MA(20) : | 2 |
| MA(100) : | 2.28 |
MA(250) : | 3.05 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 30.7 |
D(3) : | 28.4 |
| RSI | RSI(14): 53.5 |
|||
| 52-week | High : | 7.9 | Low : | 0.97 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CDIO ] has closed below upper band by 43.1%. Bollinger Bands are 83.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 56 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.18 - 2.19 | 2.19 - 2.2 |
| Low: | 1.95 - 1.96 | 1.96 - 1.98 |
| Close: | 2.01 - 2.03 | 2.03 - 2.05 |
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
Wed, 24 Jun 2026
Cardio Diagnostics Holdings (NASDAQ: CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians - TradingView
Wed, 24 Jun 2026
Atlas Healthcare will cover Cardio Diagnostics heart tests for members - Stock Titan
Wed, 24 Jun 2026
Cardio Diagnostics Company Profile & Introduction - Moomoo
Tue, 23 Jun 2026
Cardio Diagnostics Holdings (CDIO) Targets a $393B Heart Disease Problem With Epigenetics and AI - Yahoo Finance
Tue, 23 Jun 2026
Cardio Diagnostics Holdings (NASDAQ: CDIO) Targets a $393B Heart Disease Problem with Epigenetics and AI - TradingView
Fri, 19 Jun 2026
CDIO Should I Buy - Intellectia AI
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 2.83e+006 (%) |
| Held by Institutions | 8.3 (%) |
| Shares Short | 47 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -6.27e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -66 % |
| Return on Assets (ttm) | 598.4 % |
| Return on Equity (ttm) | -38 % |
| Qtrly Rev. Growth | 16570 % |
| Gross Profit (p.s.) | 84.13 |
| Sales Per Share | -29.82 |
| EBITDA (p.s.) | 7531.81 |
| Qtrly Earnings Growth | -3.4 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.07 |
| Price to Cash Flow | 1.48 |
| Dividend | 0 |
| Forward Dividend | 19270 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|